Gilead Sciences
Founded:
1987
Investments:
29
Exits:
10
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Portfolio companies:
Kyverna Therapeutics,Goldfinch Biopharma,Pionyr Immunotherapeutics,Vineti,Tizona Therapeutics,Lyndra Therapeutics,Tmunity Therapeutics
BioTech
CloudTech
Enterprise
Software
–
Series C
Series D
Series B
United States